Thermoregulation is one of the most precisely regulated homoeostatic functions in mammals, as hyperthermia or hypothermia beyond the normal range can rapidly turn into a life or death situation. Under cold stress, mammals maintain their euthermic body temperature by preventing heat loss and producing extra heat through shivering and non-shivering (adaptive) thermogenesis. Brown adipose tissue (BAT) is a specific organ for adaptive thermogenesis and its principal function is to generate heat through an oxidative process not coupled to ATP synthase, but mediated by the mitochondrial uncoupling protein 1 (UCP1)[@b1][@b2][@b3]. The sympathetic nervous system (SNS) regulates lipolysis and UCP1 expression in BAT, and vasoconstriction in skin, both of which are critical factors for balancing heat production and heat loss[@b1][@b4]. The SNS also modulates the expression of peroxisome proliferator-activated receptor γ co-activator-1α (ppargc1α and PGC-1α), which is an indispensable regulator for cold-induced upregulation of UCP1 (refs [@b5], [@b6]). Although essential roles of the SNS and PGC-1α/UCP1 pathway have been confirmed by the cold intolerance phenotype of knockout mice lacking the gene for dopamine β-hydroxylase[@b7], β-adrenergic receptors (β-ARs)[@b8], PGC-1α[@b6] or UCP1 (ref. [@b2]), the molecular mechanisms of how this pathway is regulated *in vivo* have not been precisely defined.

Adaptive thermogenesis is a major component of energy expenditure. As obesity occurs when energy intake exceeds energy expenditure, increasing the expenditure by enhancing adaptive thermogenesis could lead to the prevention of obesity[@b9]. While the physiological relevance of BAT in human adults was controversial, recent studies by positron emission tomography have clearly shown its presence and metabolic function[@b10][@b11][@b12][@b13]. Regulatory factors of adaptive thermogenesis in BAT, thus, might be a potential therapeutic target for obesity[@b9][@b14].

Nardilysin (*N*-arginine dibasic convertase; *Nrd1* and NRDc) is a zinc peptidase of the M16 family, which selectively cleaves dibasic sites[@b15][@b16]. Enzymatic activity of NRDc appears to be required for antigen processing and the generation of cytotoxic T-lymphocyte epitopes[@b17]. NRDc is mainly localized in the cytoplasm as it has no apparent signal sequence, but a significant proportion is secreted through an unconventional secretory pathway and distributed on the cell surface[@b18]. We identified NRDc on the cell surface as a specific binding partner of heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), and demonstrated that NRDc enhances the ectodomain shedding of HB-EGF and other membrane proteins through the activation of A disintegrin and metalloproteinase (ADAMs)[@b19][@b20][@b21][@b22]. Furthermore, critical roles of NRDc as an enhancer of shedding have been implicated in nervous system development[@b23], Alzheimer's disease[@b24] and cancer biology[@b25]. Interestingly, NRDc has been demonstrated to shuttle between the cytosol and nucleus[@b26][@b27] and NRDc has been recently identified as a dimethyl-H3K4-binding protein, suggesting a novel role of NRDc in transcriptional regulation[@b28].

Here we demonstrate that NRDc-deficient (*Nrd1*^*−/−*^) mice show hypothermia and severe cold intolerance, which are attributed to lowered set point of body temperature, poor thermal insulation and impaired cold-induced BAT thermogenesis. Our studies also revealed that NRDc and PGC-1α interact and co-localize in the UCP1 enhancer where NRDc regulates PGC-1α activity and UCP1 transcription. These results indicate that NRDc critically regulates body temperature homoeostasis, in part, through the modulation of PGC-1α activity.

Results
=======

Hypothermia and severe cold intolerance in *Nrd1* ^*−/−*^ mice
--------------------------------------------------------------

We previously reported that *Nrd1*^*−/−*^ mice show growth retardation[@b23]. Analysis of body composition of *Nrd1*^*−/−*^ mice by cross-sectional computed tomography (CT) revealed a lean phenotype of *Nrd1*^*−/−*^ mice ([Fig. 1a](#f1){ref-type="fig"}). The ratios of body fat mass to total body weight (BW) and to lean mass were significantly reduced in *Nrd1*^*−/−*^ mice compared with *Nrd1*^*+/+*^ littermates ([Fig. 1b,c](#f1){ref-type="fig"}). As these results suggested a negative energy balance in *Nrd1*^*−/−*^ mice, we examined food intake and energy expenditure. While both *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice showed similar *ad libitum* food intake per BW ([Fig. 1d](#f1){ref-type="fig"}), average energy expenditure, measured as oxygen consumption (VO~2~), was 28.5% higher in *Nrd1*^*−/−*^ mice ([Fig. 1e](#f1){ref-type="fig"}). During a whole day *ad libitum* feeding, VO~2~ per total BW of *Nrd1*^*−/−*^ mice was consistently higher than that of *Nrd1*^*+/+*^ mice ([Fig. 1f](#f1){ref-type="fig"}). Two major components of energy expenditure are physical activity and adaptive thermogenesis[@b4]. Monitoring of animal movement showed that *Nrd1*^*−/−*^ mice are more active than *Nrd1*^*+/+*^ mice ([Fig. 1g](#f1){ref-type="fig"}), partially explaining the enhanced energy expenditure of *Nrd1*^*−/−*^ mice. To determine whether increased adaptive thermogenesis contributes to the enhanced energy expenditure, we examined the resting core body temperature and cold tolerance of *Nrd1*^*−/−*^ mice. Unexpectedly, even at room temperature (23 °C), the core body temperature of *Nrd1*^*−/−*^ mice was significantly lower than that of *Nrd1*^*+/+*^ mice (*Nrd1*^*+/+*^: 38.0±0.08 °C, *Nrd1*^*−/−*^: 36.4±0.14 °C, the mean±s.e.m., measured in light period, *n*=6, *P*\<0.0001, two-tailed Student's *t*-test; [Fig. 1h](#f1){ref-type="fig"}).

We next exposed 3-month-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice to 4 °C. Mice on both genotypes responded to cold exposure by shivering, indicating that *Nrd1*^*−/−*^ mice could sense the cold temperature. *Nrd1*^*−/−*^ mice showed severe and prolonged shivering at 1.5 h after the initiation of cold exposure ([Supplementary Movie 1](#S1){ref-type="supplementary-material"}), whereas *Nrd1*^*+/+*^ mice showed minimal shivering ([Supplementary Movie 2](#S1){ref-type="supplementary-material"}). These observations suggested that adaptive thermogenesis in *Nrd1*^*−/−*^ mice is impaired. Whereas *Nrd1*^*+/+*^ mice kept their body temperature at around 36.5 °C by the end of 3 h cold exposure after an initial drop of \~1.5 °C, *Nrd1*^*−/−*^ mice were surprisingly intolerant to cold exposure as their body temperature dropped below 30 °C within 2 h and below 15 °C within 3 h ([Fig. 1i](#f1){ref-type="fig"}). As a control, we exposed younger *Nrd1*^*+/+*^ mice that had similar BW similar to 3-month-old *Nrd1*^*−/−*^ mice to 4 °C. As expected, younger *Nrd1*^*+/+*^ mice were able to maintain their body temperature at around 36.5 °C by the end of 3 h cold exposure, indicating that cold intolerance of *Nrd1*^*−/−*^ mice is not merely because of their smaller body mass ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}).

Cold-induced thermogenesis is impaired in *Nrd1* ^*−/−*^ mice
-------------------------------------------------------------

To clarify the underlying mechanism of hypothermia and cold intolerance in *Nrd1*^*−/−*^ mice, we first examined the histopathology of BAT, which generates heat mainly through the mitochondrial uncoupler, UCP1. Unexpectedly, we found that lipid accumulation in BAT was substantially lower in *Nrd1*^*−/−*^ than *Nrd1*^*+/+*^ mice at postnatal day 30 (P30), P90 and even at P180 ([Fig. 2a](#f2){ref-type="fig"}). Electron microscopy at P14 showed that the size of lipid vacuoles was much smaller in *Nrd1*^*−/−*^ BAT, which resulted in the reduced cell size and relative increase of the mitochondrial density in *Nrd1*^*−/−*^ adipocytes ([Fig. 2b](#f2){ref-type="fig"}). Electron micrograph images at a higher magnification revealed no structural abnormality in the mitochondria of *Nrd1*^*−/−*^ BATs ([Fig. 2c](#f2){ref-type="fig"}). Notably, much more capillary vessels with larger diameters were found in *Nrd1*^*−/−*^ BAT ([Fig. 2b](#f2){ref-type="fig"}), indicating that *Nrd1*^*−/−*^ BAT is supplied with more blood flow compared with *Nrd1*^*+/+*^ BAT. The vascular-rich phenotype was not observed in other tissues such as the liver and skin, implying an increased oxygen requirement specifically for BAT. In spite of the hypothermic phenotype of *Nrd1*^*−/−*^, these histological features indicate that *Nrd1*^*−/−*^ BAT is metabolically more active, producing more heat than *Nrd1*^*+/+*^ BAT. To examine whether NRDc is involved in adipogenic differentiation, primary culture of preadipocytes was prepared from *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ BAT and differentiated into adipocytes. Cellular morphology was similar and oil red O staining revealed no clear differences in lipid accumulation between the two genotypes, indicating that NRDc is not involved in adipogenic differentiation ([Supplementary Fig. 2a,b](#S1){ref-type="supplementary-material"}).

Cold-induced thermogenesis is mediated through the sympathetic activation of β3-AR (*Adrb3*) on brown adipocytes, which is followed by induction of a transcriptional co-activator PGC-1α, resulting in increased expression of UCP1 (refs [@b1], [@b4]). In PGC-1α-deficient BAT, cold-induced upregulation of UCP1 is markedly reduced, indicating that the PGC-1α/UCP1 pathway is essential for adaptive thermogenesis[@b6]. Consistent with the histological findings, messenger RNA (mRNA) levels of PGC-1α, UCP1 and β3-AR at room temperature were significantly higher in *Nrd1*^*−/−*^ BAT ([Fig. 3a](#f3){ref-type="fig"}). However, while *Ppargc1α*, *Ucp1* and *Adrb3* in *Nrd1*^*+/+*^ BAT were dramatically induced by cold exposure, *Ppargc1α* and *Ucp1* were not induced and *Adrb3* was significantly decreased in *Nrd1*^*−/−*^ BAT ([Fig. 3a](#f3){ref-type="fig"}). As the blunted induction suggested that cold-induced adaptive thermogenesis is impaired in *Nrd1*^*−/−*^ mice, we measured BAT temperature (*T*~BAT~) *in vivo* under cold exposure. Repeated skin cooling consistently increased *T*~BAT~ in *Nrd1*^*+/+*^ mice, but not in *Nrd1*^*−/−*^ mice, confirming that adaptive thermogenesis is severely impaired in *Nrd1*^*−/−*^ BATs *in vivo* ([Fig. 3b](#f3){ref-type="fig"}; [Supplementary Table 1](#S1){ref-type="supplementary-material"}). However, the tachycardic response to cooling was intact in *Nrd1*^*−/−*^ mice, indicating that cutaneous temperature sensation is normal in *Nrd1*^*−/−*^ mice ([Fig. 3b](#f3){ref-type="fig"}; [Supplementary Table 1](#S1){ref-type="supplementary-material"}).

Poor insulation and lowered set point in *Nrd1* ^*−/−*^ mice
------------------------------------------------------------

As the thermoneutral zone for mice is around 30 °C, mice have to generate heat at room temperature (23 °C) to maintain their body temperature[@b29]. The lean phenotype of *Nrd1*^*−/−*^ mice suggest that they are poorly insulated, which may cause enhanced adaptive thermogenesis to compensate lost heat. To explore this possibility, we measured VO~2~ of 6-month-old *Nrd1*^*−/−*^ mice at 23 and 30 °C. Similar to 3-month-old mice ([Fig. 1f](#f1){ref-type="fig"}), VO~2~ of 6-month-old *Nrd1*^*−/−*^ mice was significantly higher than that of *Nrd1*^*+/+*^ mice at 23 °C. Notably, *Nrd1*^*−/−*^ mice showed hypermetabolism even at 30 °C, albeit the difference in energy expenditure between *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice was smaller at 30 °C ([Fig. 4a--c](#f4){ref-type="fig"}). As the slope of increasing metabolism with decreasing ambient temperature shows the level of insulation[@b29], these results indicate that *Nrd1*^*−/−*^ mice are less insulated than *Nrd1*^*+/+*^ mice ([Fig. 4e](#f4){ref-type="fig"}). Simultaneous monitoring of physical activities demonstrated that *Nrd1*^*−/−*^ mice are more active than *Nrd1*^*+/+*^ mice at night, but not at daytime ([Fig. 4a,b,d](#f4){ref-type="fig"}). Therefore, the higher VO~2~ of *Nrd1*^*−/−*^ mice, at least at daytime, is due to increased thermogenesis. Consistent with these results, BAT mRNA levels of UCP1 and β3-AR in *Nrd1*^*−/−*^ mice showed clear tendencies to be higher than *Nrd1*^*+/+*^ mice even after 10 days housing at 30 °C, although no difference in PGC-1α was observed under this condition ([Supplementary Fig. 3](#S1){ref-type="supplementary-material"}). These findings indicated that BAT thermogenesis is primarily enhanced in the mutant mouse, and further enhanced to compensate poor insulation at room temperature.

To test the capacity of BAT thermogenesis at thermoneutrality, we next examined the effect of β3 agonist on the metabolism at 23 and 30 °C. At 23 °C, *Nrd1*^*+/+*^ mice responded to β3 agonist injection with a sharp increase of VO~2~, whereas *Nrd1*^*−/−*^ mice showed high basal metabolism and did not respond to β3 agonist injection ([Fig. 5a,c](#f5){ref-type="fig"}). In contrast, at 30 °C, *Nrd1*^*−/−*^ mice responded to β3 agonist from the decreased basal level ([Fig. 5b,c](#f5){ref-type="fig"}). These results indicated that *Nrd1*^*−/−*^ mice can induce BAT thermogenesis, at least, in the narrow range of higher ambient temperature around 30 °C.

If hypothermia of *Nrd1*^*−/−*^ mice at 23 °C is merely due to impaired BAT thermogenesis, their body temperature may rise when they are in the thermoneutral zone. However, the 1.5 °C difference in body temperature between *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice was still evident at 30 °C and even at 33 °C ([Fig. 5d](#f5){ref-type="fig"}). These results suggest that the hypothermia of *Nrd1*^*−/−*^ mice is caused by lowered set point of body temperature.

To rule out the possibility that impaired cold-induced thermogenesis is due to the reduced lipid substrate in *Nrd1*^*−/−*^ BAT, we fed mice with a high-fat diet (HFD). After being fed with HFD for 3 months, *Nrd1*^*−/−*^ mice showed a dramatic increase in BAT lipid accumulation similar to *Nrd1*^*+/+*^ mice ([Supplementary Fig. 4](#S1){ref-type="supplementary-material"}). *Nrd1*^*−/−*^ mice, however, were unable to increase their body temperature even when the fuel source for heat production was overloaded by HFD. These results further suggest the lowered set point of body temperature in *Nrd1*^*−/−*^ mice.

NRDc regulates PGC-1α and its downstream target genes
-----------------------------------------------------

While *in vivo* analysis at the thermoneutrality suggested that BAT thermogenesis is primarily upregulated in *Nrd1*^*−/−*^ mice, NRDc ablation in neural or hormonal systems might have indirectly affected thermogenesis. To assess the direct effects of NRDc on BAT thermogenesis, we measured the expression level of PGC-1α, UCP1 and β3-AR in brown adipocyte primary cultures treated with microRNA (miR) targeting NRDc. Similar to the expression pattern in *Nrd1*^*−/−*^ BAT *in vivo* at room temperature, NRDc-knocked down cells showed increased mRNA levels of PGC-1α, UCP1 and β3-AR ([Fig. 6a](#f6){ref-type="fig"}) and increased protein levels of UCP1 ([Fig. 6b](#f6){ref-type="fig"}), indicating the cell autonomous repressive effect of NRDc on the expression of these thermogenic factors. Next, we examined the effect of forskolin, an activator of PKA, on *ppargc1α* and *Ucp1* induction in immortalized brown adipocytes derived from *Nrd1*^*+/−*^ and *Nrd1*^*−/−*^ BAT. The basal mRNA levels of PGC-1α and UCP1 were significantly higher in *Nrd1*^*−/−*^ cells compared with *Nrd1*^*+/−*^ cells, whereas levels induced by forskolin were similar in *Nrd1*^*+/−*^ and *Nrd1*^*−/−*^ brown adipocytes ([Fig. 6c](#f6){ref-type="fig"}). These results indicate that the regulation of *ppargc1α* and *Ucp1* is impaired in *Nrd1*^*−/−*^ BAT both *in vivo* and *in vitro*.

We next examined the direct effect of NRDc on the transcriptional activity of *ppargc1α*. Luciferase reporter assay using a 2-kb mouse *ppargc1aα* promoter[@b30] showed that NRDc overexpression significantly inhibits the forskolin-induced transcriptional activity of *ppargc1α*, confirming that NRDc negatively regulates *ppargc1α* transcription ([Fig. 6d](#f6){ref-type="fig"}). As PGC-1α is a transcriptional co-activator that functions as a master regulator of oxidative metabolism[@b31], we next asked whether gene knockdown of NRDc affects target genes of PGC-1α other than *Ucp1*. mRNA levels of multiple genes involved in the mitochondrial oxidative metabolism were increased by gene knockdown of NRDc in a primary culture of brown adipocytes ([Fig. 6e](#f6){ref-type="fig"}). Notably, the same set of oxidative genes was also upregulated in *Nrd1*^*−/−*^ BAT *in vivo* ([Fig. 6f](#f6){ref-type="fig"}). Results from these gain and loss of function studies establish that NRDc is an important upstream regulator of PGC-1α.

NRDc in the UCP1 enhancer negatively regulates PGC-1α activity
--------------------------------------------------------------

NRDc shuttles between the cytosol and nucleus[@b26][@b27]. Recent data have also demonstrated that NRDc is a dimethyl-H3K4-binding protein with transcriptional repressor activity[@b28]. Thus, we examined whether nuclear NRDc is directly involved in the transcriptional regulation of PGC-1α. We confirmed the nuclear expression of NRDc in brown adipocytes by western blotting of nuclear fractions ([Fig. 7a](#f7){ref-type="fig"}) and immunocytochemical analysis ([Fig. 7b](#f7){ref-type="fig"}). The specificity of the anti-mouse NRDc monoclonal antibody used in these experiments was validated using cells derived from *Nrd1*^*−/−*^ mouse ([Supplementary Fig. 5a](#S1){ref-type="supplementary-material"}). Nuclear expression of NRDc was also detected in BAT of wild-type mice ([Supplementary Fig. 5b](#S1){ref-type="supplementary-material"}). Furthermore, nuclear NRDc was quickly reduced by isoproterenol treatment for 2 h ([Fig. 7a](#f7){ref-type="fig"}). The decrease of nuclear NRDc probably occurred at the post-translational level, because mRNA level of NRDc was not affected either by forskolin treatment in brown adipocytes or by cold exposure in mice ([Figs 6c](#f6){ref-type="fig"} and [3a](#f3){ref-type="fig"}). On the other hand, protein levels of β3-AR and UCP1 did not change by the treatment ([Fig. 7a](#f7){ref-type="fig"}), although mRNA levels were upregulated by forskolin ([Fig. 6c](#f6){ref-type="fig"}).

The recruitment of PGC-1α to the peroxisome proliferator-activated receptor-responsive element (PPRE) in the promoter has been shown to be critical for transcriptional activation of *Ucp1* (refs [@b32], [@b33], [@b34]). Chromatin immunoprecipitation (ChIP) assay using anti-PGC-1α monoclonal antibodies showed that the association of PGC-1α with *Ucp1* promoter is clearly increased by gene knockdown of NRDc in brown adipocytes ([Fig. 7c](#f7){ref-type="fig"}). These results indicated that NRDc not only controls the transcription of PGC-1α, but also its recruitment to the promoter region of *Ucp1*. ChIP analysis also showed that NRDc binds to the PPRE in the *Ucp1* promoter, which was significantly decreased by β-agonist treatment ([Fig. 7d](#f7){ref-type="fig"}). These results demonstrated that the transcriptional activation of *Ucp1* is accompanied with the removal of NRDc from its enhancer region. As ChIP analysis indicated that both NRDc and PGC-1α exist in the PPRE of *Ucp1* promoter, we performed sequential ChIP--re-ChIP experiments to determine the *in vivo* co-localization of NRDc and PGC-1α. Sequential immunoprecipitation by antibodies against NRDc and PGC-1α demonstrated that the two factors co-localize in the PPRE of *Ucp1* enhancer ([Fig. 7e](#f7){ref-type="fig"}).

We next assessed whether NRDc and PGC-1α physically interact by two methods. First, immunoprecipitation with either anti-FLAG (FLAG-PGC-1α) or anti-V5 (NRDc-V5) demonstrated that NRDc and PGC-1α co-immunoprecipitate from co-transfected cell lysates ([Fig. 8a](#f8){ref-type="fig"}; [Supplementary Fig. 6](#S1){ref-type="supplementary-material"}). Second, pull-down assays demonstrated that recombinant NRDc binds to PGC-1α protein containing the first 400 amino acids ([Fig. 8b](#f8){ref-type="fig"}). Finally, the effect of NRDc on the transcriptional co-activator function of PGC-1α was assessed by the reporter activity driven by Gal4-PGC-1α (ref. [@b5]). NRDc repressed the transcriptional activity of Gal4-PGC-1α in a dose-dependent manner when introduced into COS7 cells with Gal4-PGC-1α ([Fig. 8c](#f8){ref-type="fig"}). To assess whether enzymatic activity of NRDc is required for the repressor function, mouse embryonic fibroblast (MEF) cells isolated from *Nrd1*^*−/−*^ mice were used for the reporter assay. Re-introduction of wild-type NRDc, but not an enzymatically inactive mutant, repressed Gal4-PGC-1α-induced transcriptional activity. Altogether, these findings establish that NRDc binds to PGC-1α and negatively regulates PGC-1α activity through its metalloendopeptidase activity.

Discussion
==========

In this study, we demonstrate that *Nrd1*^*−/−*^ mice show hypothermia and severe cold intolerance. At room temperature (23 °C), *Nrd1*^*−/−*^ mice showed increased energy expenditure. The histological features and upregulated expression of UCP1 in *Nrd1*^*−/−*^ BAT indicated that *Nrd1*^*−/−*^ BAT produces more heat at room temperature than *Nrd1*^*+/+*^ BAT. Enhanced energy expenditure of *Nrd1*^*−/−*^ mice is, thus, due to increased thermogenesis and hyperactivity. Despite these features, *Nrd1*^*−/−*^ mice were severely intolerant to cold. Several independent criteria suggested that this is due to impaired cold-induced BAT thermogenesis and poor thermal insulation in *Nrd1*^*−/−*^ mice. We found that cold induction of PGC-1α and UCP1 was almost completely lost in *Nrd1*^*−/−*^ BAT. Our data also indicated that skin cooling- and β3 agonist-induced heat production in BAT are markedly reduced in *Nrd1*^*−/−*^ mice. Furthermore, *Nrd1*^*−/−*^ mice showed severe and prolonged shivering even at 1.5 h after the initiation of cold exposure, which may be an attempt to compensate for the impaired BAT thermogenesis. These results suggested that thermogenesis in *Nrd1*^*−/−*^ BAT reaches a plateau at room temperature and cannot be further induced by cold exposure. This interpretation was also supported by the observation that VO~2~ of *Nrd1*^*−/−*^ mice at 23 °C was as high as that of *Nrd1*^*+/+*^ mice after β3 agonist injection. The metabolism of *Nrd1*^*−/−*^ mice, however, was markedly reduced in the thermoneutral zone (30 °C). The difference of VO~2~ between *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice was narrowed by raising the ambient temperature, although metabolism of *Nrd1*^*−/−*^ mice was still significantly higher than that of *Nrd1*^*+/+*^ mice at 30 °C. These results indicate that BAT thermogenesis is primarily enhanced in the mutant mouse, and further enhanced to compensate for the poor insulation at room temperature. It is not clear at present why *Nrd1*^*−/−*^ mice are poorly insulated because the appearance and microstructure of skin appear normal in *Nrd1*^*−/−*^ mice (data not shown). Although *Nrd1*^*−/−*^ mice respond normally to cold by shivering and increasing their heart rate, cold-induced cutaneous vasoconstriction and/or pilomotor reflex might be impaired, which are subjects of future studies.

Notably, in the thermoneutral zone, β3 agonist-induced thermogenesis was rescued in *Nrd1*^*−/−*^ mice. These results indicate that *Nrd1*^*−/−*^ mice can normally produce heat, at least, at the limited range of high ambient temperature around 30 °C. In spite of the normal thermogenic capacity, body temperature of *Nrd1*^*−/−*^ mice stayed 1.5 °C lower than that of *Nrd1*^*+/+*^ mice at 30 °C, and even at 33 °C. These results indicate that hypothermia of *Nrd1*^*−/−*^ mice is not due to the impaired thermogenesis, but probably due to the downregulation of the central set point of body temperature. In addition, body temperature of *Nrd1*^*−/−*^ mice remained the same after high fat feeding, which induced a remarkable increase of BAT lipid accumulation, further supporting the lowered set point of body temperature in *Nrd1*^*−/−*^ mice. As NRDc is expressed in neurons and regulates axonal maturation and myelination[@b23], neuronal abnormalities of *Nrd1*^*−/−*^ mice may contribute to the central setting of body temperature. To the best of our knowledge, among genetically modified mice, only thyroid hormone receptor α-deficient (TRα^*−/−*^) mice have been reported to have a lower set point of body temperature[@b35]. Given that PGC-1α was shown to interact with TRβ and activate its transcriptional activity[@b5][@b36], NRDc might cooperate with TR for the central regulation of body temperature.

One of the most debated issues on the analysis of energy expenditure is how to normalize VO~2~ for differences in BW[@b29]. The BW of *Nrd1*^*−/−*^ mice is approximately half as much as that of *Nrd1*^*+/+*^ mice owing to the severe growth retardation ([Supplementary Fig. 7a](#S1){ref-type="supplementary-material"}). Since there is no complete method for comparing metabolism of animals with such different BW, we had to draw conclusion by unifying several results of different experimental approaches. *Nrd1*^*−/−*^ mice showed hyperactivity, enhanced BAT thermogenesis and decreased body fat, whereas their food intake per BW was similar to that of *Nrd1*^*+/+*^ mice. Considering the energy balance, these results certainly indicate that energy expenditure is increased in *Nrd1*^*−/−*^ mice. While VO~2~ per BW was reasonably higher in *Nrd1*^*−/−*^ mice, VO~2~ per animal was consistently lower in *Nrd1*^*−/−*^ mice relative to *Nrd1*^*+/+*^ mice owing to the small body size of *Nrd1*^*−/−*^ mice ([Supplementary Fig. 7b--d](#S1){ref-type="supplementary-material"}). These observations justify the usage of VO~2~ per BW for this specific case. Furthermore, VO~2~ per BW of *Nrd1*^*+/+*^ mice at 23 °C reached the very same level as that of *Nrd1*^*−/−*^ mice after β3-agonist injection. VO~2~ per BW of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice at 30 °C was also similar after β3-agonist injection. Since the excess amount of β3 agonist should induce the maximum level of thermogenesis, these results indicated that *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice have a similar maximum capacity of metabolism per BW. On the other hand, VO~2~ per animal in *Nrd1*^*−/−*^ mice was lower than that in *Nrd1*^*+/+*^ mice both before and after β3-agonist injection because of the small body size ([Supplementary Fig. 7e--g](#S1){ref-type="supplementary-material"}). These observations also support the use of VO~2~ per BW for the metabolism index.

In addition to the *in vivo* analysis demonstrating the primary effect of NRDc on BAT thermogenesis, our *in vitro* studies also established the cell autonomous effect of NRDc on the expression of thermogenic genes in the primary culture of BAT. NRDc regulates the PGC-1α/UCP1 pathway by two distinct mechanisms: regulation of *ppargc1α* transcription and PGC-1α recruitment to the promoter of *Ucp1*. Although a direct interaction of endogenous NRDc with endogenous PGC-1α remains to be demonstrated, our data suggest that NRDc represses PGC-1α activity and *Ucp1* transcription by binding to PGC-1α. On activation, removal of NRDc from the complex derepresses the co-activator function of PGC-1α, allowing it to activate *Ucp1* transcription (upper panel: [Supplementary Fig. 8](#S1){ref-type="supplementary-material"}). In the absence of NRDc, the basal levels of PGC-1α and UCP1 activation are upregulated. However, further activation of PGC-1α and UCP1 by β-stimulant is impaired in the absence of NRDc (lower panel: [Supplementary Fig. 8](#S1){ref-type="supplementary-material"}). How β-stimulant regulates the interaction of NRDc and PGC-1α remains to be determined.

The stability and activity of PGC-1α are known to be regulated by post-translational mechanisms, such as acetylation and phosphorylation[@b37][@b38][@b39]. Thus, removal of NRDc might facilitate PGC-1α modification by enzymes, such as kinases, followed by PGC-1α activation possibly through the recruitment of the histone acetyltransferase complex[@b40]. Alternatively or concurrently, NRDc may inhibit PGC1α activity by modulating the co-repressor function of the NCoR/SMRT complex. We found that the three subunits of NCoR/SMRT complex: SMRT, NCoR and HDAC3 are associated with NRDc[@b28]. Although the precise functions of NCoR and HDAC3 in BAT biology have yet to be fully defined, these observations suggest that NRDc may control thermogenesis by modulating the activity of the co-activator and co-repressor complex on the UCP1 promoter.

We identified NRDc as a cell surface-binding partner of HB-EGF[@b19]. Our subsequent studies demonstrated that NRDc enhances the ectodomain shedding of not only HB-EGF but also of amyloid precursor protein, tumour necrosis factor-α and neuregulin-1 (refs [@b20], [@b21], [@b22], [@b23]). Critical roles of NRDc as an enhancer of shedding have been implicated in nervous system development[@b23], Alzheimer's disease[@b24] and cancer biology[@b25]. While the metalloendopeptidase activity of NRDc is dispensable for the enhancement of ectodomain shedding[@b20], NRDc was shown to be required for antigen processing and the generation of cytotoxic T-lymphocyte epitopes through its enzymatic activity[@b17]. On the other hand, NRDc has been identified as a novel histone-binding protein, specifically recognizing dimethyl-H3K4 (ref. [@b28]). It remains to be determined whether the regulatory role of NRDc on PGC-1α, described in the present study, is related to the dimethyl-H3K4-binding capacity. Although we show here that the metalloendopeptidase activity of NRDc is required for its repressing effect on PGC-1α activity, there is no experimental evidence for the cleavage of PGC-1α by NRDc. The enzymatic activity might alter, for example, the nuclear uptake of NRDc. Future studies addressing the exact mechanism by which the enzymatic activity regulates transcription are needed. Given the observed localization-dependent multiple functions of NRDc, it will be important to clarify the trafficking mechanism of NRDc in future.

Methods
=======

Animal experiments
------------------

*Nrd1*^*−/−*^ mice (accession number CDB0466K, <http://www.cdb.riken.jp/arg/mutant%20mice%20list.html>) were generated by gene targeting in TT2 (ref. [@b41]) embryonic stem cells. The targeting vector was designed to replace exon 1 with DT-A/lox71/LacZ-pA/frt/PGK-Neo/frt/loxP/pA cassette ( <http://www.cdb.riken.jp/arg/cassette.html>)[@b23]. Twelve-week-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice (both male and female) were used unless otherwise indicated. All animal experiments were performed according to procedures approved by the Institute of Laboratory Animals, the Kyoto University. Mice were maintained on a diet of standard rodent chow or a high-fat/high-sucrose diet (Oriental yeast, F2HFHSD) in environmentally controlled rooms.

Body fat composition analysis
-----------------------------

For CT analysis of body fat composition, *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice were anaesthetized and scanned by LaTheta experimental animal CT system (LCT-100M, Aloka). Body fat mass was analysed quantitatively using LaTheta software (version 1.00) according to the manufacturer's protocol[@b42].

Respiratory gas analysis
------------------------

*Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice were held individually in a chamber at 23 or 30 °C for a week so that they could attain a constant respiratory exchange ratio. Gas analysis was performed using an open-circuit metabolic gas analysis system connected directly to a mass spectrometer (Model Arco2000; ArcoSystem)[@b43]. The VO~2~ was calculated using the following equations: VO~2~*=*\[(FEN~2~/FIN~2~) × FIO~2~−FEO~2~\] × VT × 10 where FEN~2~ is the concentration of nitrogen in the exhaust air, FIN~2~ is the concentration of nitrogen in the room air, FEO~2~ is the concentration of oxygen in the exhaust air, FIO~2~ is the concentration of oxygen in the room air and VT is the air flow through the chamber corrected to standard temperature pressure dry. To measure β-agonist-induced thermogenesis, the β~3~-adrenergic agonist BRL-37344 (Sigma) was injected intraperitoneally at 5 mg kg^−1^, and VO~2~ was measured for another 300 min.

Cold tolerance test
-------------------

For cold exposure, 12-week-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ female mice and 3-week-old *Nrd1*^*+/+*^ female mice were individually housed in cages at 4 °C for 3 h. Core body temperature was monitored by a rectal temperature (*T*~rec~) probe (Physitemp). After cold exposure, BAT was dissected and collected immediately.

Skin cooling experiment
-----------------------

The procedures for rats described elsewhere[@b44] were modified to mice. Female mice, 8--12-month old, were anaesthetized with intraperitoneal urethane (1.3 g kg^−1^) following introductory gas anaesthesia with 3% isoflurane. To monitor skin temperature, the trunk was shaved and a copper-constantan thermocouple was taped onto the abdominal skin. The trunk was placed on a plastic water jacket and the abdominal skin was cooled by perfusing the water jacket with ice-cold water and then rewarmed by switching to perfusion with warm water. *T*~rec~ was monitored using a thermocouple inserted into the rectum. *T*~rec~ was maintained by perfusing the water jacket with warm or cold water. *T*~BAT~ was monitored with a needle-type thermocouple inserted into the interscapular BAT pad.

Cell culture and viral infection
--------------------------------

COS7 cells were grown in DMEM (4.5 g l^−1^ glucose) supplemented with 10% fetal bovine serum (FBS) and antibiotics (culture medium). Brown preadipocytes were prepared from neonatal C57BL/6J mice as reported elsewhere[@b45]. In brief, interscapular BATs were minced and digested with 2 mg ml^−1^ collagenase for 1 h at 37 °C. Digested tissues were filtered through a 100-μm cell strainer to remove undigested tissues. The flow-through was then centrifuged at 800 *g* for 10 min to pellet the stromal vascular cells (preadipocytes). The cells were then resuspended and plated onto a culture dish. To knock down *Nrd1* in brown preadipocytes, cells were infected with a lentivirus expressing miR-targeting *Nrd1* (BLOCK-iT miR RNAi Select; Life Technologies). Brown preadipocytes were also established from neonatal *Nrd1*^*+/+*^, *Nrd1*^*+/−*^ and *Nrd1*^−*/−*^ mice. These preadipocytes were immortalized by infection of retrovirus expressing SV40 T antigen followed by selection with G418. Adipogenic differentiation was performed as described elsewhere[@b46]. In brief, cells were grown to confluence in DMEM (4.5 g l^−1^ glucose) supplemented with 10% FBS, antibiotics and 17 μM pantothenic acid, 33 μM biotin, 100 μM ascorbic acid, 1 μM octanoic acid and 50 nM 3,3′,5-triiodo-[L]{.smallcaps}-thyronine (adipocyte culture medium). Differentiation was induced by treating confluent cells for 48 h in adipocyte culture medium supplemented with 10 mg ml^−1^ insulin and 2.5 μM dexamethasone. After induction, the culture medium was changed to adipocyte culture medium supplemented only with 10 mg ml^−1^ insulin and cells were cultured for following 96 h. All experiments with the brown fat cells were performed after differentiation, unless otherwise indicated. MEF cells were isolated from *Nrd1*^−*/−*^ embryos at embryonic day 14.5 (E14.5), and were maintained in DMEM containing 5% FBS, 100 U ml^−1^ of penicillin, 100 mg ml^−1^ of streptomycin and 2 mM [L]{.smallcaps}-glutamine. MEF were passed according to the 3T3 protocol and immortalized[@b23].

Antibodies and immunoblot analysis
----------------------------------

Rat anti-mouse NRDc monoclonal antibodies (clone \#1 and \#135) and rabbit anti-mouse NRDc polyclonal antibody were raised against recombinant mouse NRDc in our laboratory. Recombinant mouse NRDc (full length) was synthesized using silkworm protein expression system (Sysmex). Mouse anti-PGC-1α monoclonal antibodies (clone \#3 and \#16) were raised against recombinant mouse PGC-1α (1-400) fused with glutathione *S*-transferase (GST) in our laboratory. PGC-1α (1-400) fused with GST was prepared in BL21 strain and synthesized according to the manufacturer's instruction (Amersham Biosciences). Other antibodies were from the following sources; UCP1 (Sigma, U6382), Lamin A/C (Santa Cruz, sc-6215), β3-adrenergic receptor (Chemicon, AB5124) and β-actin (Santa Cruz, sc47778). For immunoblot analysis, primary antibodies were used at the following dilutions: rat anti-mouse NRDc monoclonal antibody (clone \#1) at 1:2,000; rabbit anti-mouse NRDc polyclonal antibody at 1:2,500; anti-PGC-1α monoclonal antibody (clone \#16) at 1:2,000; UCP1 at 1:1,000; Lamin A/C at 1:1,000; β3-adrenergic receptor at 1:1,000; β-actin at 1:2,500. Preparation of total cell extract and immunoblot analysis were carried out as described previously[@b20]. In brief, cells were lysed in lysis buffer containing 10 mM Tris--HCl pH 7.4, 150 mM NaCl, 1% NP-40 and protease inhibitor cocktail (Roche). Cell lysates were separated by SDS--polyacrylamide gel electrophoresis and transferred to nitrocellulose filters. After blocking, filters were incubated with primary antibodies, followed by horseradish peroxidase-conjugated secondary antibodies. The immobilized peroxidase activity was detected with the enhanced chemiluminescence system (Amersham Biosciences). For isolation of nuclei, brown adipocytes were suspended in hypotonic buffer (10 mM HEPES (pH 7.9), 1.5 mM MgCl~2~, 10 mM KCl, 0.1 mM EDTA, 0.1% NP-40, 1 mM dithiothreitol, protease inhibitor cocktail (Complete Mini; Roche) and phosphatase inhibitor cocktail (Sigma)), followed by homogenization and centrifugation (2,500 r.p.m., 5 min, 4 °C). Extraction of nuclear fraction was carried out by resuspension of collected nuclei in high salt buffer (20 mM HEPES (pH 7.9), 1.5 mM MgCl~2~, 400 mM NaCl, 0.1 mM EDTA, 10% glycerol, 0.1% NP-40, 1 mM dithiothreitol, protease inhibitor cocktail (Complete Mini; Roche) and phosphatase inhibitor cocktail (Sigma), followed by centrifugation (20,400*g*, 5 min, 4 °C).

Immunostaining and oil red O staining
-------------------------------------

Immunocytochemistry was performed as described previously[@b20]. In brief, fixed differentiated brown adipocytes were immunostained with rat anti-mouse NRDc (clone \#135 at 1:200 dilution) and Alexa Fluor 488-conjugated goat anti-rat IgG antibodies (A-11006 at 1:500 dilution), followed by the counterstaining with 4\',6-diamidino-2-phenylindole. Stained cells were observed with a Zeiss LSM510 META laser scanning confocal microscope. Immunohistochemistry was performed with deparaffinized sections as described previously[@b23]. In brief, mice were anaesthetized and transcardially perfused with 4% paraformaldehyde (PFA) in PBS. Tissues were post-fixed in 4% PFA for 16 h and embedded in paraffin and sectioned at 6 μm thickness on a microtome. For oil red O staining, differentiated brown fat cells were fixed with 3.7% formaldehyde and stained with 0.3% (w/v) oil red O solution in 60% isopropyl alcohol.

Electron microscopy
-------------------

Mice were anaesthetized and fixed via transcardial perfusion with 4% PFA and 2% glutaraldehyde in 0.1 M phosphate buffer. A block of \~2 mm^3^ of BAT was removed from interscapular area, incubated for 2 h at 4 °C in the same fixative and contrasted with 1% osmic acid in PBS. Tissues were dehydrated in an ethanol gradient from 50--100% and embedded in epon. Semi-thin sections (0.9 μm) were stained with toluidine blue for survey by light microscopy. Ultra-thin sections (80 nm) were cut and stained with 2% uranyl acetate (Watson's modified method) and Reynolds lead citrate, and analysed with HITACHI H-7650 transmission electron microscope.

Quantitative real-time PCR analysis
-----------------------------------

Total RNA was purified from snap-frozen BAT and from differentiated brown adipocytes using Trizol reagent (Life Technologies) according to the manufacturer's protocol. First-strand complementary DNA was synthesized from total RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche). Quantitative reverse transcription--PCR was carried out using the ABI Prism 7700 Sequence Detection System and SYBR Green MASTER (Roche) following the manufacturer's directions (Applied Biosystems). The results were standardized for comparison by measuring levels of Actb mRNA in each sample. The primers used in these studies are shown in [Supplementary Table 2](#S1){ref-type="supplementary-material"}.

Luciferase reporter assays
--------------------------

PGC-1α promoter 2 kb luciferase[@b30] and Gal4-PGC-1α (ref. [@b5]) are generous gifts from B.M. Spiegelman. (UAS)x3-TK/luciferase and Gal4-DBD are generous gifts from D. Moore. A cDNA encoding full length of mouse NRDc was cloned into pcDNA3.1/V5-His to generate pcDNA3.1-mNRDc-V5. A cDNA encoding an enzymatically inactive mutant of mouse NRDc was obtained by substituting the Glu^237^ codon (GAG) with an Ala codon (GCG) using the PCR technique (pcDNA3.1-mNRDc-E\>A-V5). For luciferase assays, COS7 or MEF cells were transiently transfected with various combinations of expression and reporter plasmids using HilyMax (Dojindo). Forty eight hours after transfection, cells were lysed and analysed by using the Dual-Luciferase Reporter Assay Kit (Promega) according to the manufacturer's protocol.

ChIP and Re-ChIP assay
----------------------

Mature brown adipocytes were treated with or without 10 μM isoproterenol for 2 h and crosslinked with 1% formaldehyde in culture medium for 10 min. Cells were collected and resuspended in hypotonic solution, followed by isolation of nuclei, which were lysed in nuclear lysis buffer (50 mM Tris--Cl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1 mM EDTA, 0.1% sodium deoxycholate and protease inhibitors). ChIP assays were performed using ChIP-IT Express Chromatin Immunoprecipitation Kits (Active Motif). In brief, chromatin-bound proteins were immunoprecipitated with antibodies against NRDc (rabbit polyclonal anti-mouse NRDc), PGC-1α (clone \#3) or control IgG (Abcam). One-twentieth of the purified DNA after ChIP was subjected to qPCR analysis using following primers targeting the PPRE of the UCP1 enhancer: forward 5′-TCACCCTTGACCACACTGAA-3′, reverse 5′-GTGAGGCTGATATCCCCAGA-3′. Results were normalized with qPCR results using 1% of the total chromatin subject to ChIP. For re-ChIP assay, immunoprecipitates were eluted after the first ChIP. The eluate was diluted and subjected to the second ChIP.

GST pull-down assay
-------------------

Plasmids, pGEX-PGC-1α (1-400), were a kind gift from B.M. Spiegelman[@b40]. GST fusion proteins were prepared in BL21 strain and purified on glutathione-Sepharose 4B (Amersham Biosciences). In pull-down assay, 15 μl of a 50% slurry of GST fusion proteins bound to the beads were incubated with 500 ng of recombinant mouse NRDc in 200 μl PBS containing 0.1 mg ml^−1^ BSA for overnight at 4 °C. The beads were washed and eluted proteins were analysed by SDS--polyacrylamide gel electrophoresis followed by Coomassie blue staining and immunoblotting.

Statistical analysis
--------------------

All results are presented as the mean±s.e.m. Statistical analyses were done by two-tailed Student's *t*-test for comparisons of two groups. Analysis of variance and appropriate *post hoc* analysis were used for comparisons of more than three groups.
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Nrd1^+/+^ mouse under cold-exposure. This movie shows a Nrd1^+/+^ mouse at 1.5 h after the initiation of cold-exposure
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![Increased energy expenditure, hypothermia and cold intolerance of *Nrd1*^*−/−*^ mice.\
(**a**) Representative CT sections of abdominal regions of 3-month-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice. Scale bars, 10 mm. (**b**,**c**) Ratio of total fat to BW (**b**) or to lean mass (**c**) was calculated from CT scan data. Pink areas show visceral fat, while yellow areas show subcutaneous fat. *n*=3 per genotype. (**d**) Food intake was measured daily for 7 days and normalized to BW. *n*=5 per genotype. (**e**,**f**) VO~2~ of 3-month-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice was monitored in 10 min intervals for 24 h (**f**) and the average VO~2~ for 24 h is shown (**e**). *n*=6 per genotype. (**g**) Physical activity was monitored for 7 days. The average movement counts are shown. *n*=6 per genotype. (**h**,**i**) Body temperature of 3-month-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice at room temperature (**h**) and after cold (4 °C) exposure (**i**). *n*=6 per genotype. All data represent means±s.e.m. \**P*\<0.05, \*\**P*\<0.005, \*\*\**P*\<0.001, ^†^*P*\<0.0001, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f1){#f1}

![Decreased lipid accumulation and increased blood vessels in *Nrd1*^*−/−*^ BAT.\
(**a**) Haematoxylin and eosin-stained sections of BAT of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice at P30, P90 and P180. Scale bars, 100 μm. (**b**) Electron micrographs of BAT at P14. The same set of pictures, in which blood vessels are painted in red, are shown in the right panel. Scale bars, 10 μm. (**c**) Electron micrographs of BAT at P14 at a high magnification. Scale bars, 500 nm.](ncomms4224-f2){#f2}

![Impaired cold-induced thermogenesis in *Nrd1*^*−/−*^ mice.\
(**a**) Quantitative reverse transcription--PCR analysis for genes involved in adaptive thermogenesis in BAT before (23 °C) and after 3 h cold exposure (4 °C). The mRNA level is normalized by β-actin mRNA, and the level is arbitrarily set at 1 in *Nrd1*^*+/+*^ BAT at room temperature. *n*=6 per genotype. (**b**) Representative trunk skin cooling (*T*~skin~)-evoked changes in *T*~BAT~, heart rate (HR) and *T*~rec~. All data represent means±s.e.m. \**P*\<0.05, \*\**P*\<0.005, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f3){#f3}

![VO~2~ at different ambient temperature indicates poor insulation of *Nrd1*^*−/−*^ mice.\
(**a**,**b**) VO~2~ (upper) and physical activities (lower) of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice were monitored at 23 °C (**a**) or 30 °C (**b**). *n*=6 per genotype and temperature. (**c**,**d**) The average VO~2~ (**c**) and activities (**d**) during dark and light period of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice housed at 23 or 30 °C. *n*=6 per genotype and temperature. (**e**) Relationship between metabolic rates and ambient temperature. The average VO~2~ of *Nrd1*^*+/+*^ (white) and *Nrd1*^*−/−*^ (black) mice was plotted against ambient temperature (at 23 and 30 °C). All data represent means±s.e.m. \*\*\**P*\<0.001, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f4){#f4}

![β3 agonist-induced VO~2~ and body temperature of *Nrd1*^*−/−*^ mice.\
(**a**,**b**) VO~2~ induced by β3 agonist (BRL-37344: 5 mg kg^−1^) in *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice housed at 23 °C (**a**) or 30 °C (**b**). *n*=6 per genotype and temperature. (**c**) The average VO~2~ of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice before (Pre) and after (Post) β3-agonist injection at 23 or 30 °C. *n*=6 per genotype and temperature. (**d**) Body temperature of *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice housed at 23, 30 or 33 °C. *n*=5 per genotype and temperature. All data represent means±s.e.m. \*\*\**P*\<0.001, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f5){#f5}

![NRDc regulates transcription of PGC-1α and its downstream target genes.\
(**a**) mRNA levels of thermogenic genes in primary brown adipocytes transduced with lentivirus vector expressing either a control miR or miRs targeted to *Nrd1*. *n*=6. (**b**) Protein levels of NRDc and UCP1 in primary brown adipocytes described in **a**. Full blots are presented in [Supplementary Fig. 9](#S1){ref-type="supplementary-material"}. (**c**) mRNA levels of PGC-1α and UCP1 in mature immortalized brown adipocytes derived from *Nrd1*^*+/−*^ and *Nrd1*^*−/−*^ BAT in the presence or absence of forskolin treatment for 2 h. *n*=6. (**d**) Transcriptional activity of *ppargc1α* promoter-driven reporter gene in response to NRDc expression in the presence or absence of forskolin treatment in COS7 cells. *n*=5. (**e**) mRNA levels of PGC-1α target genes in primary brown adipocytes transduced with lentivirus vector as described in **a**. *n*=6. (**f**) mRNA levels of PGC-1α target genes in BAT of 12-week-old *Nrd1*^*+/+*^ and *Nrd1*^*−/−*^ mice. *n*=6. All data represent means±s.e.m. \**P*\<0.05, \*\**P*\<0.005, \*\*\**P*\<0.001, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f6){#f6}

![NRDc coexists with PGC-1α at the UCP1 enhancer.\
(**a**) Western blot analysis of cytosolic and nuclear fraction of mature brown adipocytes treated for 2 h with or without isoproterenol (ISO) by indicated antibodies. Full blots are presented in [Supplementary Fig. 9](#S1){ref-type="supplementary-material"}. (**b**) Mature brown adipocytes stained with anti-NRDc antibody and 4\',6-diamidino-2-phenylindole were visualized by confocal microscopy. Scale bars, 20 μm. (**c**) ChIP with anti-PGC-1α antibody followed by qPCR demonstrates that *Nrd1* knockdown in mature brown adipocytes increases PGC-1α recruitment to PPRE of the UCP1 enhancer. Results were normalized with input DNA, and are shown as the ratio to that in the control miR-treated cells (IP: αPGC-1α). *n*=5. (**d**) ChIP with anti-NRDc antibody followed by qPCR demonstrates that ISO treatment decreases NRDc binding to PPRE of the UCP1 enhancer. Results are shown as the fold induction relative to that in cells without ISO treatment (IP: Control IgG). *n*=4. (**e**) ChIP/re-ChIP analysis was performed with anti-NRDc and PGC-1α antibodies followed by qPCR targeting the PPRE of the UCP1 enhancer. *n*=3. All data represent means±s.e.m. \**P*\<0.05, (two-tailed Student's *t*-test).](ncomms4224-f7){#f7}

![NRDc binds to PGC-1α and negatively regulates its transcriptional activity.\
(**a**) COS7 cells were transfected with the indicated expression vectors, followed by immunoprecipitation of the co-transfected cell lysates with anti-FLAG (PGC-1α) antibody. Twenty percent of input was blotted with anti-V5 (NRDc) in the bottom lane. Full blots are presented in [Supplementary Fig. 9](#S1){ref-type="supplementary-material"}. (**b**) Pull-down assay using recombinant mouse NRDc and GST fusion proteins containing the first 400 amino acids of PGC-1α immobilized on glutathione-Sepharose beads. After the incubation, the beads were boiled and the eluted proteins were stained with Coomassie (left panel) and blotted with anti-NRDc (right upper panel) or anti-PGC-1α (right lower panel) antibody. Full blots are presented in [Supplementary Fig. 9](#S1){ref-type="supplementary-material"}. (**c**) Luciferase reporter assay using COS7 cells transfected with Gal4-PGC-1α and different dose of NRDc. *n*=5. (**d**) Luciferase reporter assay using MEF^−/−^ cells transfected with Gal4-PGC-1α and wild-type NRDc (WT) or enzymatically inactive NRDc (E\>A). Protein expression of WT and E\>A in cell lysates was confirmed by western blot with anti-NRDc antibody (bottom panel). Full blots are presented in [Supplementary Fig. 9](#S1){ref-type="supplementary-material"}. *n*=5. All data represent means±s.e.m. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, NS, not significant (two-tailed Student's *t*-test).](ncomms4224-f8){#f8}
